DRUG ANTIBODY CONJUGATES

Drug conjugates having formula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, (I) wherein D is covalently attached via a hydroxy or amine group to (X)b if any, or (AA)w...

Full description

Saved in:
Bibliographic Details
Main Authors CUEVAS MARCHANTE, María Del Carmen, FRANCESCH SOLLOSO, Andrés M, LATORRE LOZANO, Alfonso, MARTÍNEZ BARRASA, Valentín
Format Patent
LanguageEnglish
Spanish
Published 09.01.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Drug conjugates having formula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, (I) wherein D is covalently attached via a hydroxy or amine group to (X)b if any, or (AA)w if any, or to (T)g if any, or (L); that are useful in the treatment of cancer. Los conjugados de la fórmula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab en donde: D es un resto de la droga con la siguiente fórmula (I) o una sal, ester, solvato, tautómero o esteroisómero suyo farmacéuticamente aceptable, en donde D sen encuentra unido covalentemente mediante un grupo hidroxi o amino con (X)b si lo hubiera, o (AA)w si lo hubiera, o a T)g si lo hubiera, o a (L); que son útiles en el tratamiento del cáncer.
Bibliography:Application Number: CR20220000581